Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Balti
Observed name:
M. balti
Institution:
Military Hospital of Tunis
Observed institutions:
Military Hospital of Tunis,
Hôpital de la Timone
OpenAlex ID:
A5010400767
Determination of uracil/UH2 ratio as a potential surrogate for DPD status in cancer patients presenting with severe toxicities during fluoropyrimidine treatment
2006
·
C. Mercier
, C. Yang
, et al.
·
Journal of Clinical Oncology
·
4
96eP Frailty and malnutrition as prognostic factors in advanced endometrial cancer: A real-world study from Tunisia
2026
·
C. Belfekih Hassen
, I. Lajnef
, et al.
·
ESMO Open
PDF
2840P Therapeutic education: A catalyst for relieving vomiting, nausea, anxiety, and depression in cancer patients
2025
·
I. Lajnef
, J.B. Ayari
, et al.
·
Annals of Oncology
EPV011/#170 Adjuvant chemotherapy-induced amenorrhea in luminal breast cancer patients: a strong prognostic factor in Tunisian premenopausal women
2021
·
A. Zribi
, I. Ben Abdallah
, et al.
·
International Journal of Gynecological Cancer
PDF
EPV012/#171 Endocrine therapy-induced alopecia in patients with breast cancer in Tunisia
2021
·
A. Zribi
, S. Ben Nasr
, et al.
·
International Journal of Gynecological Cancer
PDF
196P Menopausal symptoms in premenopausal patients with luminal early breast cancer developing chemotherapy-induced amenorrhea
2020
·
A. Zribi
, I. Ben Abdallah
, et al.
·
Annals of Oncology
PDF
Pf313 New Treatment for Double/triple Hit Lymphoma With Dose Intense Protocol: Rituximab,doxorubicin,etoposide,prednisolone/gemcitabine+oxaliplatin Shawing Better Survival Rate
2019
·
M. Salamoon
, M. balti
, et al.
·
HemaSphere
Ps1091 Treatment of Activated B‐cell Lymphoma With Rituximab,doxorubicin,etoposide,prednisolone/ifosfamide+cisplatin Plus Lenalidomide (r‐acep/icl), Confers Long Progression Free and Overall Survival Rates
2019
·
M. Salamoon
, M. Balti
·
HemaSphere
Management of early breast cancer in Tunisia
2018
·
M. Hadoussa
, J. Ayari
, et al.
·
European Journal of Cancer
Clinical interest of the tumor marker CA15-3 in the early detection of breast cancer recurrence
2018
·
M. Hadoussa
, J. Ayari
, et al.
·
European Journal of Cancer
Plasma homocysteine, folate, vitamin B12 and risk of breast cancer
2018
·
A.B. Jihene
, M. Balti
, et al.
·
European Journal of Cancer
Facteurs predictifs d’atteinte ganglionnaire centrale dans les cancers differencies de la thyroïde. Analyses univariée et multivariée
2012
·
R. Ben Mhamed
, Sameh Mezri
, et al.
·
Journal Tunisien d ORL et de Chirurgie Cervico-Faciale
Show more works
View as search
Works count:
12
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type